About BionicM
BionicM is a company based in Tokyo (Japan) founded in 2016 by Sunny Xiaojun Sun. BionicM has raised $11.03 million across 4 funding rounds from investors including Shinsei Corporate Investment, UTokyo Innovation Platform and Kiraboshi Capital. BionicM operates in a competitive market with competitors including Proteor, CIONIC, Epica International, REEV and Instalimb, among others.
- Headquarter Tokyo, Japan
- Founders Sunny Xiaojun Sun
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.03 M (USD)
in 4 rounds
-
Latest Funding Round
$3 M (USD), Series A
Oct 08, 2024
-
Investors
Shinsei Corporate Investment
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of BionicM
Unlock access to complete
Unlock access to complete
Funding Insights of BionicM
BionicM has successfully raised a total of $11.03M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BionicM
BionicM has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Shinsei Corporate Investment, UTokyo Innovation Platform and Kiraboshi Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Accelerator and venture capital services are provided by UTokyo-backed platform.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for BionicM
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BionicM
Investment portfolio details for BionicM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BionicM
Detailed financials for BionicM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bionicm Comparisons
Peer comparison for BionicM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BionicM
BionicM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Proteor, CIONIC, Epica International, REEV and Instalimb, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Prostheses and orthoses devices are developed for orthopedic supports.
|
|
| Locked | Locked | Locked |
Bionic clothing is provided for mobility impairment support.
|
|
| Locked | Locked | Locked |
Provider of robotic CT platforms for healthcare and industrial applications
|
|
| Locked | Locked | Locked |
AI-powered exoskeletons and gait tools are developed for mobility recovery.
|
|
| Locked | Locked | Locked |
Customized 3D-printed prosthetics for leg amputees are developed.
|
Detailed competitors of BionicM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bionicm
Complete news archive for BionicM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BionicM
BionicM was founded in 2016 and raised its 1st funding round 3 years after it was founded.
BionicM is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Sunny Xiaojun Sun is the current CEO of BionicM. They have also founded this company.
BionicM is a funded company, having raised a total of $11.03M across 4 funding rounds to date.
BionicM was established in 2016 in Tokyo, Japan, within the biomedical prosthetics sector. Prosthetic legs are developed to restore partial mobility following leg and knee amputations. Sensors are integrated to measure foot force, allowing detection of wearer movements. A technical joint is added to function as a new knee, thereby minimizing required motions for activities like standing or ascending stairs. Operations center on enhancing everyday functionality for users.
BionicM's top competitors include Epica International, REEV and Instalimb.
BionicM has 7 investors. Key investors include Shinsei Corporate Investment, UTokyo Innovation Platform, Kiraboshi Capital, Chibagin Capital, and NVenture Capital.